Gln-Olmesartan Hctz 40 mg (Olmesartan Medoxomil TABLET) 40 MG

GLN-OLMESARTAN HCTZ 40 MG tablets combine olmesartan medoxomil and hydrochlorothiazide for blood pressure management. This oral medication is designed to support cardiovascular health by promoting healthy blood pressure levels.

Strength

40 MG

Pack Size

30/90

Manufacturer / TM Owner

GLENMARK PHARMACEUTICALS CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GLN-OLMESARTAN HCTZ 40 MG tablets are commonly used to manage high blood pressure, also known as hypertension. Olmesartan medoxomil works as an angiotensin II receptor blocker, while hydrochlorothiazide is a diuretic. Together, they help to relax blood vessels and reduce fluid retention, supporting overall cardiovascular health. This combination is often prescribed for individuals who require dual-action blood pressure support.

Side Effects

When taken as directed, GLN-OLMESARTAN HCTZ 40 MG tablets may help to lower blood pressure by relaxing blood vessels and reducing fluid retention. Some users may experience common effects such as dizziness, headache, or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

GLN-OLMESARTAN HCTZ 40 MG tablets should be handled with care, especially for individuals with certain medical conditions such as kidney disease or liver impairment. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

GLN-OLMESARTAN HCTZ 40 MG tablets may interact with other medications, including certain pain relievers, anti-inflammatory drugs, and other blood pressure medications. Alcohol consumption should be avoided as it can enhance the effects of the medication and increase the risk of side effects. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

GLN-OLMESARTAN HCTZ 40 MG tablets are used to manage high blood pressure by combining olmesartan medoxomil and hydrochlorothiazide.

GLN-OLMESARTAN HCTZ 40 MG tablets are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include dizziness, headache, and fatigue. These effects are usually mild and temporary.

It is advisable to avoid alcohol while taking GLN-OLMESARTAN HCTZ 40 MG as it can enhance the medication's effects and increase side effects.

Store GLN-OLMESARTAN HCTZ 40 MG tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.